Soleno Therapeutics Inc. buy Guggenheim
Start price
21.11.23
/
50%
€24.30
Target price
21.11.24
€36.55
Performance (%)
92.92%
Price
16.07.24
€46.88
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Soleno Therapeutics Inc. has seen massive gains of 92.92%. This prediction currently runs until 21.11.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Soleno Therapeutics Inc. | 22.338% | 22.338% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $40.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat